Cargando…
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial
BACKGROUND: Mesenchymal stromal cell (MSC) transplantation can improve the left ventricular ejection fraction (LVEF) after an acute myocardial infarction (AMI). Transplanted MSCs exert a paracrine effect, which might be augmented if repeated doses are administered. This study aimed to compare the ef...
Autores principales: | Attar, Armin, Farjoud Kouhanjani, Mohsen, Hessami, Kamran, Vosough, Massoud, Kojuri, Javad, Ramzi, Mani, Hosseini, Seyed Ali, Faghih, Marjan, Monabati, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517503/ https://www.ncbi.nlm.nih.gov/pubmed/37740221 http://dx.doi.org/10.1186/s13287-023-03495-1 |
Ejemplares similares
-
Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial
por: Attar, Armin, et al.
Publicado: (2022) -
Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)
por: Attar, Armin, et al.
Publicado: (2022) -
Obituary: Dr. Mohamed Taha Aljasser
por: Eldawlatly, Abdelazeem A.
Publicado: (2019) -
Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial
por: Attar, Armin, et al.
Publicado: (2022) -
Measure Twice, Cut Once
por: D’Alessandro, David A., et al.
Publicado: (2021)